… of bivalirudin versus UFH in the treatment of ECMO. Therefore, we believe it is worthwhile
to carefully conduct a meta-analysis to evaluate the efficacy and safety of bivalirudin versus …

… The efficacy and safety of bivalirudin in patients undergoing percutaneous coronary intervention
(… review and meta-analysis sought to investigate the efficacy and safety of bivalirudin as …

… Our meta-analysis was undertaken to evaluate the efficacy and safety of bivalirudin compared
with heparin in patients undergoing PCI. The meta-analysis was registered in PTOSPERO …

… as a better safety profile. We aimed to evaluate the efficacy and safety of bivalirudin use during
… This meta-analysis demonstrated that bivalirudin is associated with a lower risk of major …

… in the rate of myocardial infarction (MI) with bivalirudin and no difference in bleeding events
(5)… The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin …

… The primary safety endpoint was major bleeding up to 30 days. We calculated pooled risk
… of bivalirudin, 16 of which met the inclusion criteria and were included in the meta-analysis (…

… conducted a meta-analysis of all published prospective randomized trials and evaluated the
efficacy and safety of bivalirudin vs heparin for primary PCI. We used moderator analyses to …

… Forest plot reporting trial-specific and summary odds ratios (OR) with 95% confidence interval
(CI) for the safety comparison of bivalirudin vs. heparin with respect to major bleeding: non …

… that the benefit of bivalirudin over UFH monotherapy was driven … meta-analysis, data of
post-PCI bivalirudin infusion or cost-effectiveness were not available precluding detailed analysis …

… Unfractionated heparin (UFH), with its low cost and proven track record of overall safety and
… Bivalirudin (BIV) was found to have the advantages of inhibiting fibrin-bound thrombin, a …